Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A subset of virus-specific CD161 + T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML

Blood (2017) 129 (6): 740–758.

https://doi.org/10.1182/blood-2016-05-713347

Published: 2017

Includes: Supplemental data

Journal Articles

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Blood (2016) 128 (2): 297–312.

https://doi.org/10.1182/blood-2016-03-706317

Published: 2016

Includes: Supplemental data

Journal Articles

Eltrombopag for Post-Transplant Thrombocytopenia: Results of Phase II Randomized Double Blind Placebo Controlled Trial

Blood (2015) 126 (23): 738.

https://doi.org/10.1182/blood.V126.23.738.738

Published: 2015

Journal Articles

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Sabine FÜrst, MD, Emmanuelle Bernit, MD, Jean El Cheikh, MD, Angela Granata, MD, Samia Harbi, MD, Bilal Mohty, MD, Laurence Caymaris, Head Nurse, Claude Lemarie, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Christophe Picard, Djamel Mokart, MD PhD, Borje Andersson, MD PhD, Didier Blaise, MD

Blood (2014) 124 (21): 5792.

https://doi.org/10.1182/blood.V124.21.5792.5792

Published: 2014

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression (PTIS) and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: Safe Approach and Excellent Disease Control

Suradej Hongeng, MD, Samart Pakakasama, MD, Usanarat Anurathapan, MD, Borje Andersson, MD PhD

Blood (2014) 124 (21): 2571.

https://doi.org/10.1182/blood.V124.21.2571.2571

Published: 2014

Journal Articles

Sequential Treatment After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia.

Sairah Ahmed, MD, Rima M Saliba, Ph.D, Marcos De Lima, MD, Gabriela Rondon, MD, Partow Kebriaei, MD, Tobi DeAnn Fisher, MPAS, Elias Jabbour, MD, Julianne Chen, Hagop Kantarjian, MD, Paolo Anderlini, MD, Amin M Alousi, MD, Chitra M Hosing, MD, Borje Andersson, MD, PhD, Roy B. Jones, MD, Ph.D., Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Sergio Giralt, MD, Richard E Champlin, MD

Blood (2012) 120 (21): 3129.

https://doi.org/10.1182/blood.V120.21.3129.3129

Published: 2012

Journal Articles

International Consensus Criteria for Tyrosine Kinase Inhibitor Response and Outcome of Allogeneic Stem Cell Transplantation for CML

Sairah Ahmed, MD, Rima M Saliba, PhD, Marcos De Lima, MD, Tobi DeAnn Fisher, MPAS, Gabriela Rondon, MD, Partow Kebriaei, MD, Amin M Alousi, MD, Chitra M Hosing, MD, Qaiser Bashir, MD, Borje Andersson, MD, PhD, Richard E. Champlin

Blood (2012) 120 (21): 1997.

https://doi.org/10.1182/blood.V120.21.1997.1997

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis.

Uday Popat, Gabriela Rondon, Amin Alousi, MD, Paolo Anderlini, Borje Andersson, Chitra Hosing, Marcos de Lima, MD, Stefan Ciurea, Sergio Giralt, Partow Kebriaei, Yago Nieto, Issa Khouri, Muzaffar H Qazilbash, Roy Jones, Richard Champlin, MD

Blood (2009) 114 (22): 2283.

https://doi.org/10.1182/blood.V114.22.2283.2283

Published: 2009

Journal Articles

Autologous Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

Uday Popat, Chitra Hosing, Michelle Fanale, L. Jeffrey Medeiros, Amin M. Alousi, Sergio A. Giralt, Marcos J. de Lima, Muzaffar H. Qazilbash, Partow Kebriaei, Anas Younes, Issa Khouri, Borje Andersson, Richard Champlin, MD, Paolo Anderlini

Blood (2009) 114 (22): 2310.

https://doi.org/10.1182/blood.V114.22.2310.2310

Published: 2009

Journal Articles

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Blood (2009) 114 (22): 3394.

https://doi.org/10.1182/blood.V114.22.3394.3394

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia Transformed from Myelofibrosis

Stefan O Ciurea, MD, Marcos De Lima, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, Amin Alousi, MD, Partow Kebriaei, MD, Issa F. Khouri, MD, Paolo Anderlini, MD, Borje Andersson, MD, PhD, Chitra Hosing, MD, Srdan Verstovsek, MD, PhD, Hagop Kantarjian, MD, Richard Champlin, MD, Uday Popat, MD

Blood (2008) 112 (11): 3293.

https://doi.org/10.1182/blood.V112.11.3293.3293

Published: 2008

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Versus Conventional Chemotherapy in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) Attaining Complete Remission (CR1) Post Induction Chemotherapy: a Retrospective Case Control Study.

Yvonne A Efebera, MD, Hagop M. Kantarjian, MD, Borje Andersson, MD, Sherry Pierce, Leandro De Padua Silva, MD, Farhad Ravandi, MD, Sergio A. Giralt, MD, Gautam Borthakur, MD, Richard Champlin, MD, Marcos De Lima, MD

Blood (2008) 112 (11): 1125.

https://doi.org/10.1182/blood.V112.11.1125.1125

Published: 2008

Journal Articles

Outcomes of Allogeneic Stem Cell Transplant in Patients with Myeloid Leukemias Over 65 Years of Age. Rationale for Aggressive Therapy with Curative Intent.

Sergio Giralt, Rima M Saliba, Ph.D, Gabriela Rondon, Leandro de Padua Silva, Amin M. Alousi, Uday Popat, Marco De Lima, Borje Andersson, Partow Kebriae, MD, Paolo Anderlini, Chitra Hosing, MD, Roy Jones, Elizabeth J. Shpall, MD, Richard E. Champlin, Issa F. Khouri

Blood (2008) 112 (11): 2153.

https://doi.org/10.1182/blood.V112.11.2153.2153

Published: 2008

Journal Articles

Obesity Does Not Impact Outcome in Patients with AML/MDS Undergoing Allogeneic Transplantation.

Leandro De Padua Silva, MD, Rima M. Saliba, PhD, Marcos de Lima, MD, Grace J. Okoroji, MS, Amin Alousi, MD, Borje Andersson, MD, Chitra Hosing, MD, Elizabeth Sphall, MD, Issa Khouri, MD, Muzaffar Qazilbash, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Richard E. Champlin, MD, Roy Jones, MD, Sergio Giralt, MD, Uday Popat, MD

Blood (2007) 110 (11): 1989.

https://doi.org/10.1182/blood.V110.11.1989.1989

Published: 2007

Journal Articles

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Blood (2007) 110 (11): 1984.

https://doi.org/10.1182/blood.V110.11.1984.1984

Published: 2007

Journal Articles

A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants.

Poliana Patah, Rima Saliba, Marcelo Fernandez-Vina, Pedro Cano, Susana Pesoa, Gabriela Rondon, Borje Andersson, Sergio Giralt, Partow Kebriaei, Chitra Hosing, Paolo Anderlini, Daniel Couriel, Amin Alousi, Leandro Padua, Carlos Ramos, Richard Champlin, Marcos de Lima

Blood (2007) 110 (11): 3051.

https://doi.org/10.1182/blood.V110.11.3051.3051

Published: 2007

Journal Articles

Hyperacute GVHD: risk factors, outcomes, and clinical implications

Rima M. Saliba, Marcos de Lima, Sergio Giralt, Borje Andersson, Issa F. Khouri, Chitra Hosing, Shubhra Ghosh, Joyce Neumann, Yvonne Hsu, Jorge De Jesus, Muzaffar H. Qazilbash, Richard E. Champlin, Daniel R. Couriel

Blood (2006) 109 (7): 2751–2758.

https://doi.org/10.1182/blood-2006-07-034348

Published: 2006

Journal Articles

Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.

Paolo Anderlini, Rima M. Saliba, Sandra Acholonu, Sergio A. Giralt, Issa F. Khouri, Borje Andersson, Marcos De Lima, Chitra Hosing, Daniel Couriel, Richard E. Champlin

Blood (2006) 108 (11): 3115.

https://doi.org/10.1182/blood.V108.11.3115.3115

Published: 2006

Journal Articles

High Busulfan Exposure Is Associated with Worse Outcome in a Daily IV Busulfan and Fludarabine Transplant Regimen.

Michelle Geddes, MD, Shahbal B. Kangarloo, PhD, Farrukh Naveed, BSc, Quinlan M. Diana, RN, Ahsan Chaudhry, MD, Mary Lynn Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, PhD, Jan Storek, MD, PhD, Borje Andersson, MD, PhD, James A. Russell, MA, MB, B. Chir

Blood (2006) 108 (11): 313.

https://doi.org/10.1182/blood.V108.11.313.313

Published: 2006

Journal Articles

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Daniel R. Couriel, Chitra Hosing, Rima Saliba, Elizabeth J. Shpall, Paolo Anderlini, Beverly Rhodes, Veronica Smith, Issa Khouri, Sergio Giralt, Marcos de Lima, Yvonne Hsu, Shubhra Ghosh, Joyce Neumann, Borje Andersson, Muzzafar Qazilbash, Sharon Hymes, Stella Kim, Richard Champlin, Michele Donato

Blood (2006) 107 (8): 3074–3080.

https://doi.org/10.1182/blood-2005-09-3907

Published: 2006

NARROW

A subset of virus-specific CD161 + T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Eltrombopag for Post-Transplant Thrombocytopenia: Results of Phase II Randomized Double Blind Placebo Controlled Trial

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression (PTIS) and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: Safe Approach and Excellent Disease Control

Sequential Treatment After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia.

International Consensus Criteria for Tyrosine Kinase Inhibitor Response and Outcome of Allogeneic Stem Cell Transplantation for CML

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis.

Autologous Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia Transformed from Myelofibrosis

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Versus Conventional Chemotherapy in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) Attaining Complete Remission (CR1) Post Induction Chemotherapy: a Retrospective Case Control Study.

Outcomes of Allogeneic Stem Cell Transplant in Patients with Myeloid Leukemias Over 65 Years of Age. Rationale for Aggressive Therapy with Curative Intent.

Obesity Does Not Impact Outcome in Patients with AML/MDS Undergoing Allogeneic Transplantation.

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants.

Hyperacute GVHD: risk factors, outcomes, and clinical implications

Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.

High Busulfan Exposure Is Associated with Worse Outcome in a Daily IV Busulfan and Fludarabine Transplant Regimen.

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only